SARS News and Research

RSS

New study explains why Delta is so easily transmitted and infects people quickly

The Delta variant of SARS-CoV-2 has swept the globe, becoming the dominant variant within just a few months. A new study from Boston Children's Hospital, published today in Science, explains why Delta is so easily spread and infects people so quickly, and suggests a more targeted strategy for developing future COVID-19 vaccines and treatments.

27 Oct 2021

Study shows sustained deterioration of mental health in UK across COVID pandemic

To date, it is not clear how the COVID-19 pandemic and implementation of various preventive strategies impacted mental health or which group of people were most affected by them. To address these issues, scientists have conducted coordinated analyses that included eleven UK longitudinal population studies, comprising data from before and throughout the pandemic.

27 Oct 2021

Postpartum women's experience of social restrictions during COVID-19

A new study published on the medRxiv* preprint server has focused on the effect of various social restrictions or lack of social support on women who delivered and raised babies during the pandemic.

27 Oct 2021

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Researchers in the United States have conducted a study showing that Moderna’s coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.

26 Oct 2021

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

In the worldwide effort to battle SARS-CoV-2, the virus that causes COVID-19, researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either kill the coronavirus or lessen the impacts from its infection.

26 Oct 2021

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Researchers in the United States have developed a cost-effective, high-throughput pipeline for identifying effective nanobodies that target and neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

26 Oct 2021

Extending COVID-19 vaccinations to adolescents and children may lower the overall disease burden

A recent study by researchers from the Netherlands highlights that the introduction of vaccination programs against coronavirus disease 2019 (COVID-19) to adolescents and children may reduce infection rates and severe disease outcomes – both in these age groups and in the population as a whole. The paper is currently available on medRxiv* preprint server while it undergoes peer review.

26 Oct 2021

New technology could power a self-sustaining electronic device for detecting fever

Public temperature checks have become a common practice across the world during the COVID-19 pandemic, and researchers at Texas A&M University are working to make it possible to conduct the test across a large group of people quicker and less expensive than current methods.

26 Oct 2021

SARS News and Research

New study explains why Delta is so easily transmitted and infects people quickly

Study shows sustained deterioration of mental health in UK across COVID pandemic

Postpartum women's experience of social restrictions during COVID-19

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Extending COVID-19 vaccinations to adolescents and children may lower the overall disease burden

New technology could power a self-sustaining electronic device for detecting fever

Hyperimmune antibody produced in horses may be an efficient approach to combat covid-19

AstraZeneca ChAdOx1 nCoV-19 vaccine does not affect fertility and birth rate outcomes, study says

SARS-CoV-2 detection with natural spring water gargle instead of nasopharyngeal swabs

Brain fog in long COVID

Model suggests longer protection from SARS-CoV-2 neutralizing antibody response

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

NIH invests $74.5 million to advance data science research and spur health discoveries across Africa

UQ researchers find that SARS-CoV-2 virus does not infect blood vessels

Non-pharmaceutical interventions reduce likelihood of SARS-CoV-2 infection following high-risk exposure

Study finds SARS-CoV-2 infection is proportional to cell surface ACE2 levels

Attitudes towards COVID-19 vaccination amongst essential workers

Evaluation of COVID-19 infection risk during US spring semester in-person teaching

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News